Aims and Scope
Current Cancer Drug Targets is a peer-reviewed medical journal published by Bentham Science Publishers. The editor-in-chief is Ruiwen Zhang (UH Drug Discovery Institute). The journal covers research on contemporary molecular drug targets involved in cancer, including medicinal chemistry, pharmacology, molecular biology, genomics, and biochemistry. Current Cancer Drug Targets publishes original research reports, review papers, and rapid communications ("letters").
Key Metrics
6.4
CiteScore
CiteScore
CiteScore measures average citations received per document published in the serial.
< 5
Impact Factor
Impact Factor
Impact factor of a journal is calculated by dividing the number of current year citations to the source items published in that journal during the previous two years.
99
H index
H-Index
Journal's h-index reflects the collective citation impact of the authors publishing in the journal. The h-index is defined as the maximum value of h such that the given journal has published at least h papers that have each been cited at least h times.
Q2
Oncology
SJR
- Q3 Oncology
- Q2 Pharmacology
- Q2 Drug Discovery
- Q3 Cancer Research
SJR
SJR
SCImago Journal Rank measures weighted citations received by the serial. Citation weighting depends on subject field and prestige (SJR) of the citing serial.
0.85
SNIP
SNIP
Source Normalized Impact per Paper measures actual citations received relative to citations expected for the serial’s subject field.
Topics Covered
- Cancer
- Carcinogenesis
- Assay
- Chemotherapy
- Lung cancer
- Breast cancer
- Reactive oxygen species
- Autophagy
- Immunotherapy
- Cell activation
- Colorectal cancer
- Drug resistance
- Temozolomide
- Tumor growth
- RNA editing
- Prostate cancer
- Hepatocellular carcinoma
- Oxime
- Tumor progression
- Immune system
Journal Specifications
| Overview | |
| Publisher | BENTHAM SCIENCE PUBL LTD |
| Language | English |
| Frequency | Monthly |
| General Details | |
| Language | English |
| Frequency | Monthly |
| Publication Start Year | 2000 |
| Publisher URL | Visit website |
| Website URL | Visit website |
Planning to publish in Current Cancer Drug Targets ?
Upload your Manuscript to get
- Degree of match
- Common matching concepts
- Additional journal recommendations
Looking for the right journals to submit your mansucript?
Upload your manuscript and get a submission readiness score and other journal recommendations.
Check my PaperRecently Published Papers
-
Full paper
CREC Family Genes as Biomarkers and Therapeutic Targets in Lung Adenocarcinoma: In vitro and In silico Insights.
- 7 May 25
- Current cancer drug targets
-
Full paper
Arctigenin Suppresses Melanoma via Mitophagy Activation In vitro and Enhances Dacarbazine Sensitivity In vivo.
- 25 Apr 25
- Current cancer drug targets
-
Full paper
Ergodic Manipulation of Genome Chaos: Innovative Strategies against Malignant Progression.
- 25 Apr 25
- Current cancer drug targets
-
Full paper
Synergistic Targeting of EGFR, ESR1, BCL2, and TP53 Pathways: A Multi-Pronged Approach for Advanced Breast Cancer Therapy.
- 24 Apr 25
- Current cancer drug targets
-
Full paper
A Comprehensive Evaluation of the Effectiveness and Safety of Pembrolizumab for the Treatment of Metastatic Colorectal Cancer: A Systematic Review and Meta-Analysis.
- 23 Apr 25
- Current cancer drug targets
-
Full paper
MED10 Increases Cisplatin Resistance by Promoting PTEN Ubiquitination of Hepatocellular Carcinoma
- 3 Apr 25
- Current cancer drug targets
Scite analysis
Powered by scite_
1.9k articles received 42.5k citations see all
- 995 Supporting
- 40,848 Mentioning
- 63 Contrasting
Editorial notices
- 0 Retractions
- 3 Withdrawals
- 0 Corrections
- 0 Errata
- 0 Expression of Concern
FAQs
How long has Current Cancer Drug Targets been actively publishing?
Current Cancer Drug Targets has been in operation since 2000 till date.
What is the publishing frequency of Current Cancer Drug Targets ?
Current Cancer Drug Targets published with a Monthly frequency.
How many articles did Current Cancer Drug Targets publish last years ?
In 2024, Current Cancer Drug Targets published 155 articles.
What is the eISSN & pISSN for Current Cancer Drug Targets ?
For Current Cancer Drug Targets,eISSN is 1873-5576 and pISSN is1568-0096.
What is Citescore for Current Cancer Drug Targets ?
Citescore for Current Cancer Drug Targets is 6.4.
What is H index for Current Cancer Drug Targets ?
H index for Current Cancer Drug Targets is 99.
What is SNIP score for Current Cancer Drug Targets ?
SNIP score for Current Cancer Drug Targets is 0.85.
What is the SJR for Current Cancer Drug Targets ?
SJR for Current Cancer Drug Targets is Q2.
Who is the publisher of Current Cancer Drug Targets ?
BENTHAM SCIENCE PUBL LTD is the publisher of Current Cancer Drug Targets.